K
Karine Abboud
Researcher at Jean Monnet University
Publications - 33
Citations - 1065
Karine Abboud is an academic researcher from Jean Monnet University. The author has contributed to research in topics: Hyperthermic intraperitoneal chemotherapy & Cancer. The author has an hindex of 13, co-authored 30 publications receiving 773 citations.
Papers
More filters
Journal ArticleDOI
Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients.
Naoual Bakrin,J.M. Bereder,Evelyne Decullier,Jean-Marc Classe,Simon Msika,Gérard Lorimier,Karine Abboud,Pierre Meeus,Gwenael Ferron,François Quenet,Frédéric Marchal,Sebastien Gouy,Philippe Morice,Christophe Pomel,Marc Pocard,Frédéric Guyon,Jack Porcheron,Olivier Glehen +17 more
TL;DR: For advanced and recurrent EOC, curative therapeutic approach combining optimal CRS and HIPEC should be considered as it may achieve long-term survival in patients with a severe prognosis disease, even in patientsWith chemoresistant disease.
Journal ArticleDOI
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.
Pierre-Emmanuel Bonnot,Guillaume Piessen,Vahan Kepenekian,Evelyne Decullier,Marc Pocard,Bernard Meunier,J.M. Bereder,Karine Abboud,Frédéric Marchal,François Quenet,Diane Goéré,Simon Msika,Catherine Arvieux,Nicolas Pirro,Romuald Wernert,Patrick Rat,Johan Gagnière,Jérémie H. Lefevre,Thomas Courvoisier,Reza Kianmanesh,Delphine Vaudoyer,Michel Rivoire,Pierre Meeus,Guillaume Passot,Olivier Glehen,Fregat,Big-Renape Networks +26 more
TL;DR: Compared with CRSa, CRS-HIPEC improved OS and recurrence-free survival, without additional morbidity or mortality, and may be considered a valuable therapy for strictly selected patients with limited PMs from GC.
Journal ArticleDOI
Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?
Claramae Shulyn Chia,Benoit You,Evelyne Decullier,Delphine Vaudoyer,Gérard Lorimier,Karine Abboud,J.M. Bereder,Catherine Arvieux,Gilles Boschetti,Olivier Glehen +9 more
TL;DR: The cure rate of 11 % for patients with gastric carcinomatosis who are deemed terminal emphasizes that CRS and HIPEC should be considered in highly selected patients (low disease extent and complete CRS).
Journal ArticleDOI
Jejuno-ileal diverticulitis: Etiopathogenicity, diagnosis and management.
Radwan Kassir,Alexia Boueil-Bourlier,Sylviane Baccot,Karine Abboud,Joelle Dubois,Carmen Adina Petcu,Claire Boutet,Ugo Chevalier,Mathias Montveneur,Marie-Isabelle Cano,Romain Ferreira,Tarek Debs,Olivier Tiffet +12 more
TL;DR: D diagnosis is often difficult and delayed because clinical symptoms are not specific, and surgical resection with reestablishment of the bowel continuity is the preferred treatment option.
Journal ArticleDOI
Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: Multi-Institutional Retrospective Study
Vahan Kepenekian,Dominique Elias,Guillaume Passot,Eliane Mery,Diane Goéré,D. Delroeux,François Quenet,G. Ferron,Denis Pezet,Jean-Marc Guilloit,Pierre Meeus,Marc Pocard,J.M. Bereder,Karine Abboud,Catherine Arvieux,Cécile Brigand,Frédéric Marchal,J-M Classe,Gérard Lorimier,C. de Chaisemartin,Frédéric Guyon,Pascale Mariani,Pablo Ortega-Deballon,S. Isaac,C. Maurice,F. N. Gilly,Olivier Glehen,Gerlinde Averous,Frédéric Bibeau,D. Bouzard,A. Chevallier,S. Croce,Peggy Dartigues,S. Durand-Fontanier,L. Gouthi,Bruno Heyd,R. Kaci,R. Kianmanesh,M. H. Laverrière,Eric Leblanc,B. Lelong,A. Leroux,V. Loi,Christophe Mariette,S. Msika,P. Peyrat,Nicolas Pirro,J. Paineau,F. Poizat,Jack Porcheron,P. Rat,J.-M. Regimbeau,Emilie Thibaudeau,Jean-Jacques Tuech,S. Valmary-Degano,V. Verriele,Philippe Zerbib,Franck Zinzindohoué +57 more
TL;DR: In this paper, the authors evaluated the impact of perioperative systemic chemotherapy strategies on survival and postoperative outcomes in patients with DMPM treated with curative intent with CRS-HIPEC, using a multi-institutional database: the French RENAPE network.